Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. Get the latest in the newsroom.
Earnings surprises can significantly impact Boston Scientific's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual...
At Boston Scientific, unwavering commitment to patients translates into the highest levels of research, quality, and innovation. Read the latest press releases.
EKOS™ Clinical Data for PE - Boston Scientific Ultima RCT: EKOS™ vs AC for PE Seattle-II Trial: prospective PE study OPTALYSE PE Trial KNOCOUT PE: largest data about CDT in PE HI-PEITHO RCT: EKOS™ vs AC for PE The REAL-PE Analysis PE Disease Overview - Boston Scien...
Boston Scientific Receives FDA Approval; Vivus Drug Could Become the First New Anti-Obesity MedicationBoston Scientific Receives FDA ApprovalBoston Scientific Corporation's
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Installation - EXALT Model D Single-Use Duodenoscope - Boston Scientific Clinical Data - EXALT Model D Single-Use Duodenoscope - Boston Scientific patient-risk-factors ERCP Patient Risk Factors Whitepaper | Boston Scientific Stay up to date on EXALT Model D EXALTTM Opt-in form Completion...
A high-level overview of Boston Scientific Corporation (BSX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Revenue at Boston Scientific soars 53.6% to $3.08 billion in the second quarter. BSX Investing News, Analysis, and Tips Jun 2, 2021 6:01 PM EDT Buy-the-Dip Candidates: Cramer Likes Abbott Labs, Danaher, and Thermo Fisher These stocks that fell in the past week could be buy-the-dip op...